For the past several years, the availability of immune globulin (Ig) products has been very good, so product shortages have not played a major role in product choice. This allows clinicians to match the best product to the patient based on clinical condition and comorbidities. New products have become available, providing more treatment options. This flip chart provides an overview of currently available Ig products along with information about their sterility, stability, and clinical use.

Download to read this article in PDF document:
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations

This article is in PDF format and it requires Abobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.